India  
 
NewsR.in

Sun Pharma posts Rs 2,375.5 crore Quarter 2 net profit

IndiaTimes Wednesday, 1 November 2023
Sun Pharmaceuticals reported a 5% increase in its consolidated net profit for the second quarter of FY 2024. The company's revenue also rose by 11.3% and its EBITDA came in at Rs 3,179 crore. Sun Pharma's India formulation sales increased by 11.1%, while US formulation sales increased by 4.2%. Sun Pharma also highlighted the positive phase-3 data for Nidlegy in patients with melanoma. The company's API business saw a 5.1% increase in external sales.
0
shares		ShareTweetSavePostSend
 

You Might Like


Related news from verified sources

Sun Pharma reports strong quarter 2 sales

 Sun Pharma reported an increase of 11% in gross sales to Rs 12,031 crore with a 5% jump in net profit to Rs 2,375.5 crore for the second quarter ended September....
IndiaTimes

SBI posts 9.13% rise in consolidated net profit to Rs 16,099 crore in Q2

 The country's largest lender SBI on Saturday reported a 9.13 per cent growth in consolidated net profit for the September quarter to Rs 16,099.58 crore. The...
IndiaTimes

Natco Pharma Q2 net profit surges nearly 6X to Rs 369 crore

 Natco Pharma, a pharmaceutical company based in Hyderabad, has reported a significant increase in its consolidated net profit for the second quarter of the...
IndiaTimes